These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3777960

  • 1. [Clinical significance of a skin test (SU-PS) for immune responses in patients with gastrointestinal cancer treated with OK-432].
    Miyamoto Y, Takeshita M, Izuo M.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3229-35. PubMed ID: 3777960
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of immune status in gastric cancer using Su-Ps skin test].
    Ogawa T, Yakawa H, Ogawa K, Otani Y, Kawata H, Haga S, Kasihara T, Sakakibara N.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2221-6. PubMed ID: 6385863
    [Abstract] [Full Text] [Related]

  • 3. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
    Katada H, Nishikawa K, Yoneda T, Kitamura H, Nakajima A, Mikami R.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis].
    Horiuchi M, Sato K, Nakarai I, Shinoda A.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):468-74. PubMed ID: 2181937
    [Abstract] [Full Text] [Related]

  • 5. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H, Kikkawa H, Bando H, Sakatoku M, Hirano M, Tatsuzawa T.
    Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
    [Abstract] [Full Text] [Related]

  • 6. [The Su-polysaccharide skin test in lung cancer].
    Harada J, Horiguchi T, Oki K, Miyamoto H, Osada T.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2697-702. PubMed ID: 3307634
    [Abstract] [Full Text] [Related]

  • 7. [Immunotherapy of terminal-stage malignant tumors with the immunopotentiator OK-432--a comparison between SU-PS test-responder and -nonresponder patients].
    Yagi Y, Yagi S, Ichiki H.
    Gan No Rinsho; 1987 Jun; 33(7):815-21. PubMed ID: 3302349
    [Abstract] [Full Text] [Related]

  • 8. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
    Nakarai I, Rikitake H, Koga T, Hayashi A, Harada Y, Takamoto M, Ishibashi T, Shinoda A, Sagawa K.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on the reaction of the skin to various doses of Su-polysaccharide in cancer patients].
    Sato M, Sakai K, Kimura S, Tamaki Y, Kiyasu Y, Joko Y, Ogoshi T.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):245-9. PubMed ID: 3970550
    [Abstract] [Full Text] [Related]

  • 10. [The effect of OK-432 in the treatment of primary lung cancer].
    Kishimoto T, Okada K.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1051-6. PubMed ID: 3494430
    [Abstract] [Full Text] [Related]

  • 11. [Study on the preoperative adjuvant therapy of cancer--relation between serum and tumor tissue levels of UFT and OK-432 after administration, and skin reactions to Su-polysaccharide (Su-Ps)].
    Kumazawa H, Ishikawa M, Rei S, Saito H.
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3329-35. PubMed ID: 3120645
    [Abstract] [Full Text] [Related]

  • 12. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
    Kikkawa N, Sasai H, Kawahara T.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832
    [Abstract] [Full Text] [Related]

  • 13. [Study of in vitro OK432-induced IFN-gamma production in patients with gastric and esophageal cancers: comparison with in vitro skin tests].
    Matsumoto H, Izutani R, Terada M, Noguchi J, Shiraha S, Kuyama T, Aoki N.
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):819-25. PubMed ID: 2507900
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunotherapy of patients with terminal-stage malignant tumors with an immunopotentiator OK-432--a comparison of SU-PS test-responding and -nonresponding patients.
    Yagi Y, Yagi S.
    Int J Immunopharmacol; 1988 Jun; 10(4):451-61. PubMed ID: 3049405
    [Abstract] [Full Text] [Related]

  • 19. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 20. [The clinical value of long-term administration of OK-432 in head and neck cancer].
    Mitarai K, Tsukuda M, Tamamushi N, Mochimastu I, Kubota A, Sawaki S.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 1):945-50. PubMed ID: 3963858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.